Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
61 Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients Department of Pathology Dr. Marwa Tammam Ameen Hammam 2022
62 Immunosuppressive Effect of Intrathecal Morphine, Dexmedetomidine, or Both in Combination with Bupivacaine on Patients Undergoing Major Abdominal Cancer Surgery Department of Anesthesia, Intensive care and Pain management Dr. Samar Muhammad mansour 2022
63 Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2022
64 Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients Department of Pathology Prof. Eman Massad Zaki El-Hefny 2022
65 Differential regulation of CD45 expression on granulocytes, lymphocytes, and monocytes in COVID-19 Department of Anesthesia, Intensive care and Pain management Mohammed gamal Thabet ahmed 2022
66 Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients Department of Pathology Dr. Hanaan Ahmed Mohammed Ahmed 2022
67 Neutropenic Fever in Pediatric Patients with Cancer in South Egypt: A Report from a Single Institute Department of Pediatric Oncology Dr. Amira Mahmoud Mohammed Osman 2022
68 Immunosuppressive Effect of Intrathecal Morphine, Dexmedetomidine, or Both in Combination with Bupivacaine on Patients Undergoing Major Abdominal Cancer Surgery Department of Anesthesia, Intensive care and Pain management Dr. Shereen Mamdoh Mohamed kamal 2022
69 Immunosuppressive Effect of Intrathecal Morphine, Dexmedetomidine, or Both in Combination with Bupivacaine on Patients Undergoing Major Abdominal Cancer Surgery Department of Anesthesia, Intensive care and Pain management Prof. Sahar Abdel Baky Mohamed Ahmad 2022
70 Evaluation of CD66c expression for minimal residual disease in precursor B acute lymphoblastic leukemia Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2022